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Abstract: Coccidiostats are synthetic drugs administered to animals, especially to poultry, to cure 
coccidiosis. In this paper, we present a selective liquid chromatography-tandem mass spectrometry 
(LC-MS/MS) method to analyze residues of five synthetic coccidiostats in eggs: clazuril, diclazuril, 
robenidine, nicarbazin, toltrazuril and its two metabolites. The extraction efficiency was evaluated 
by testing several solvents, pH, different volumes and time of extraction. The clean-up procedures 
were optimized using different solid phase extraction cartridges and different eluants. 
Thechromatographic separation was achieved inreversed phase using a gradient of 0.1% formic 
acid in water and acetonitrile, whereas the MS detection was performed in negative electrospray 
ionization (ESI) for all the analytes, except for the robenidine. The developed method has been 
validated according to Commission Decision 2002/657/CE. The validation parameters, as linearity, 
precision, recovery, specificity, decision limit (CCα), detection capability (CCβ), and robustness 
have been determined. The proposed method resulted simple, fast, and suitable for screening and 
confirmation purposes. 
Keywords: synthetic coccidiostats; eggs; mass spectrometry 
 
1. Introduction 
Coccidiosis is a parasitic disease caused by the development and multiplication of coccidiain 
the intestine cells. It is caused by the development and multiplication of coccidian protozoa 
belonging to the Eimeria (the most predominant) or Cryptosporidium species. This infection is not 
lethal in healthy animals, but it can cause weight loss, low growth, and intestinal lesions, and every 
year, it leads to severe losses in meat and egg production [1]. 
Coccidiostats are drugs that are administered against the coccidiosis both for prophylactic 
chemotherapy and for health care [2]. To this aim, two different kinds of drugs are employed: 
ionophores and synthetic drugs. They are administrated in feed and/or in zootechnical supplements 
and some of them are included in the European Union register of Feed Additives [3]. In this paper, 
we investigated the simultaneous detection and quantification of clazuril, diclazuril, robenidine, 
nicarbazine and toltrazuril (including its main metabolites) in eggs (Figure 1). 
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Figure 1. Molecular structures of the investigated coccidiostats and of the internal (ISTD) and 
external standards (SSTD). 
Toltrazuril after administration to chicken by drinking water, is absorbed, metabolized and 
excreted as toltrazuril sulfone (main metabolite) and toltrazuril sulfoxide. Toxicology, metabolism 
and its characteristics are reported in the Summary Report on toltrazuril of the European agency for 
the evaluation of medicinal products [4,5]. Its use is regulated by Commission Regulation N 
37/2010[6]. 
Diclazuril is administered orally, and it is excreted by feces [7]. Diclazuril and toltrazuril act 
effectively against a large spectrum of coccidia. The first one is usually added to feed (about 1ppm) 
for prevention purposes, whereas the other is added to water for disease care. Clazuril shows the 
same chemical-physical properties and acting way of diclazuril [8]. 
Nicarbazin is the equi-molar complex of 4,4-dinitrocarbanilide (DNC) and 2-hydroxy-4,6 
dimetylpyrimidine (HDP) and it is administered by feed. 
The DNC moiety is metabolized and excreted more slowly respect to HDP; consequently most 
of residue analyses for nicarbazin are based on determination methods for DNC moiety. Nicarbazin, 
being strongly electrostatic, can lead to cross contamination of feed production lines after milling of 
medicated feed [9]. 
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Robenidine is administered by feed, like nicarbazin, and may give rise to phenomena of cross 
contamination [10]. In the past, it was discarded because of phenomenon of drug resistance, but it 
was then reintroduced for coccidian resistance to ionophores. 
As a result of cross-contamination in feed intended for different species, the Commission 
decided to publish a Regulation 610/2012 [11], reviewing the allowable value of certain coccidiostats, 
previously set by the Regulation 124/2009 [12]. 
Several analytical methods have been developed for the analysis of one or more coccidiostats in 
different biological matrixes and with different techniques, as reported by Mortier et al. [13]. Most of 
the works use a chromatographic technique, especially high-performance liquid chromatography 
coupled with ultraviolet detectoror mass spectrometric detector [14–28]. 
High resolution liquid chromatography-UV technique was used for the determination of 
nicarbazin and robenidine in eggs and in feeds [14–17]. Several authors used an HPLC-MS technique 
for single and multiresidual determination of these compounds in eggs, in muscle and in feedstuffs 
[18–25] reaching a lower Limit of Detection (LOD) than HPLV-UV. Sample preparation is a critical 
step in the analysis of coccidiostats [26], and sometimes highly specific and selective methods like 
immunoaffinity chromatography (IAC) can be used, [27], but this procedure, however, is very long, 
complex and expensive for routine analysis. 
In 2012, a multiresidue method, including 20 coccidiostats, in eggs [28] was published. Five 
grams of egg were extracted by 20 mL of CH3CN and after evaporation of the volume to dryness, the 
residue was reconstituted and injected to HPLC-MS/MS. Clazuril was not included in this study. 
Recently, an exhaustive review [29] summarized the analyses of coccidiostats in meat and other 
food. 
At the moment, there are few papers about toltrazuril and its metabolites in eggs or in 
feedstuffs [30–32] and, to our knowledge, there are no scientific works about these five synthetic 
coccidiostats and the toltrazuril metabolites all together. 
Due to the massive use of these drugs in poultry, in this study, we proposed a method for a 
simultaneous determination of the mentioned five synthetic coccidiostats in eggs together with 
toltrazuril metabolites, in order to be applied in research and routine control laboratories. 
Starting from the literature about the topic and according to other authors [33], considering the 
ion suppression in the electrosray ionization to be one of the main problems (when analyzing drugs 
in complex matrices like eggs), we optimized a liquid–liquid extraction and solid phase extraction 
(SPE) purification of analytes before the analysis by liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) in multiple reaction monitoring MRM mode. To this aim, several 
extraction solvents, extraction time, solvent volume, pH of extraction, clean-up cartridges and 
solvent for the elution were investigated for the highest recovery of the analytes from the eggs, and 
the results were evaluated to study the efficacy of the method. At the end, after the optimization of 
the mass spectrometric parameters and chromatographic conditions, the proposed method was 
validated according to Commission Decision 2002/657/CE [33,34]. 
2. Materials and Methods 
2.1. Chemicals, Reagents and Solutions  
Toltrazuril (TOL), Robenidine (ROB) hydrochloride, Chloroamphenicol (CAP) (External 
Standard ES), Diclazuril (DCLAZ) were from VETRANAL®, Fluka, Sigma-Aldrich (Milwaukee, WI, 
USA); Clazuril (CLAZ), Diclazuril (DCLAZbis) bis (Internal Standard ISTD) were from Janssen 
Animal Health (Beerse, Belgium); Nicarbazin (NIC) was from Sigma-Aldrich (Milan, Italy); 
Toltrazuril-d3 (TOL-d3) (ISTD), Toltrazuril sulfone, Toltrazuril sulfoxide were from Witega 
Laboratorien Berlin-Adlershof GmbH, Magnustrasse, (Berlin, Germany). Acetonitrile (AcN), 
methanol (MeOH), Ethyl-acetate (HPLC grade), acetone, ammonium acetate, ammonium formate 
(RPE), ammonium hydroxide, ammonium sulphate (RPE) were from Carlo Erba reagents (Milan, 
Italy). Dimethylformamide (DMF) was from R.P. Normapur AR, VWR (West Chester, PA, USA). 
Formic acid (98%–100%) and acetic acid were from Merck (Darmstadt, Germany). Water was HPLC 
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grade (generated by Milli-Q biocel, Millipore, purification system(Merck S.p.a. Vimodrone (MI) 
Italy). 
Individual stock standard solutions were prepared at a concentration of 1 mg/mL. 
Solvents used were: DMF for clazuril, diclazuril e nicarbazin and methanol for robenidine, 
toltrazuril, toltrazuril sulfone and toltrazuril sulfoxide. The stock solutions were stored at −20°C. 
Working solutions were prepared by diluting stock solutions in acetonitrile to obtain solutions 
from 100 to 10 μg/mL. Standard mixtures were daily prepared by mixing adequate volume of each 
working solution and diluting in water-acetonitrile (30/70 v/v) up to a final concentration between 
0.001and 1.0µg/mL. To enhance the quantification and the robustness of the method two internal 
standards were used: toltrazuril-d3 for toltrazuril, toltrazuril sulfone and toltrazuril sulfoxide; and 
diclazuril-bis for diclazuril, clazuril and robenidine. Stock solution were prepared in DMF for 
diclazurilbis and in methanol for toltrazuril-d3 and stored at −20 °C. 
2.2. HPLC-MS/MS Apparatus and Conditions  
The LC system was a PE LC-200 Micro Pump (binary pump, vacuum degasser, autosampler AS 
200) (Perkin-Elmer Sciex Instruments, Milan, Italy) coupled to a Triple Quadrupole LC-MS/MS Mass 
Spectrometer API2000 (Applied Biosystem, Foster, CA, USA) The MS system was controlled by 
Analyst software (version, Applied Biosystem, Foster, CA, USA). A chromatographic separation was 
achieved on reversed phase system using a C18column (5µm,150mm × 2.1mm), Gemini, Phenomenex 
(Torrance, CA, USA) protected by a guard column containing the same packing material. Gradient 
elution was performed, starting from 70% of 0.1% aqueous formic acid (A) and acetonitrile (B) up to 
20% A and 80% B in 15 min. Flow rate was 0.2 mL/min. A syringe pump (Harvard apparatus, 
Holliston, MA,USA) was connected to the interface for tuning purposes and to add ammonium 
hydroxide (0.08%) post column, before the mass spectrometer. All the experiments were performed 
in ESI (electrospray ionization) in negative mode, except for the robenidine, acquired in positive 
ionization. For each compound, the protonated or deprotonated molecular ion, [M+H]+or [M − H]−, 
was chosen as a precursor and was subsequently fragmented by nitrogen, also used as drying and 
nebulising gas. The source block and desolvatation temperature were set at 120°C and 380 °C, 
respectively. Dwell time was around 100 ms for each analyte. 
2.3.Sample Preparation 
One gram of homogenized eggs, purchased from the local market, was weighed in a falcon 
tube. Furthermore, 50 μL of the internal standard solution of TOL-d3andDCLAZbis were added to 
all samples. At this step, if necessary, samples were spiked by a specific amount of analyte standard 
solution mixture. The samples were then vortexed and allowed to stand for 15 min. Samples were 
extracted by 5 mL of AcN, placed in a ultrasonic bath for 5 min, then placed in a horizontal shaker 
for 20 min and finally centrifuged for 5 min at 4000 rpm. The supernatant (5mL) was transferred into 
a graduated tube, diluted up to 25 mL with Milli-Q water and passed through a polymeric cartridge 
SPE Varian (60mg) (Varian, Palo Alto, CA,USA), pre-activated with 3 mL of methanol and washed 
with 5 mL water. Two washing steps, using 5mL of water and subsequently 5% aqueous MeOH, 
were tested before the elution with 5 mL of MeOH. The eluate was evaporated to dryness, using 
nitrogen at 40°C. In addition, 50μL of CAP solution (100ng/mL) in aqueous AcN (70%) was used to 
reconstitute the dried residue and aliquots of 5 µL were injected into the LC–ESI-MS/MS system on a 
C18 column. 
3. Result and Discussion 
3.1. Optimization of the Chromatographic and Mass Spectrometric Conditions 
Firstly, all the chromatographic conditions were optimized. Since all of the investigated 
compounds have an absorption in the UV region (between 240 and 350nm), preliminary 
experiments were performed by HPLC with a diode array detector to select the column and the most 
suitable chromatographic conditions for the purpose (data not shown). Three C18 columns were 
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tested: a Discovery, Supelco, (Sigma Aldrich, Milan, Italy), a Zorbax (Agilent, 20063 Cernusco sul 
Naviglio, MI, Italy), and a Gemini (Phenomenexsrl40013 – Castel Maggiore, Bo Italy) 4.6 ×150mm, 5 
μm at a flow rate of 1 mL·min−1. The best selectivity was obtained by Gemini C18column. Since the 
mobile phase composition has a significant effect on the peak shape and on the retention behavior of 
the analyte in the LC column, as well as on the MS response, modifications of the mobile phase 
(water-MeOH and water-AcN) in isocratic and gradient conditions with different additives were 
also tested. 
The best performance, in terms of the mobile phase, was obtained by 0.1%formic acid-AcN in 
gradient elution with the addition of ammonium hydroxide (0.08%) at the exit of the column, prior 
to the mass spectrometer, in order to increase the ionization response. 
As expected, the limits of quantifications (LOQs) were too high for the legal limits imposed for 
these substances; therefore, the method was further readapted to LC-MS/MS analysis and then 
validated according to the Commission Decision 2002/657/CE. The development of an MRM 
LC/MS/MS method requires experiments carried out by infusion at 10 µL·min−1 of standard solutions 
(2.5–10 ng·µL−1), in order to determine suitable source parameters for the best sensitivity and signal 
to noise S/N ratio, as well as the molecule-related ions. 
First of all, we selected the more effective ionization mode (ESI vs. Atmospheric pressure 
chemical ionization—APCI), enhancing the formation of protonated/deprotonated molecular ions of 
the target analytes. Experiments were carried out in negative and positive polarity using different 
mobile phase mixtures (MeOH and AcN) and additives such as: formic and acetic acid, ammonium 
formate and acetate, NH3 and water. All the instrumental parameters, and potentials, such as ion 
source voltage (IS), cone potential (CP), and collision energy (CE), were optimized in order to 
maximize the quasi-molecular ion intensities on Q1 and the MS/MS transitions in Q3.The best results 
were obtained operating with ammonium formate 20 mM (Figure 2) in negative ion mode for all 
compounds, except for robenedine, more efficiently ionized in positive ion mode. 
 
Figure 2. Effect of different additives in the mass spectrometric response of the investigated analytes. 
For qualitative purposes, a minimum of 3.5 identification points are necessary. In LC-MS/MS, 
the transition of one precursor ion into two product ions corresponds to four identification points, 
and this criterion is accomplished except for diclazuril, toltrazuril and toltrazuril sulfone because 
they have only one fragment as a product ion. In this case, we used two precursor ions and one 
fragment from each precursor.  
All the transitions and the optimized electrical parameters are reported in Table1. For the 
development of the method to detect nicarbazin, we focused on the DNC moiety. 
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Finally, all of the analyses were performed in HPLC-MS/MS in MRM mode, according to 
Section 2.2 and acquired the most intense transitions from Table 1. To gain detection sensitivity, NH3 
was added post column to the eluate prior to the mass spectrometer. The analytes were eluted in less 
than 12 min. 
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Table 1.Summary of electric parameters, precursor and fragment ions chosen for the multiple reaction monitoring (MRM) analysis and chromatographic retention 
times. 
Compound Ionization 
m/zPrecursor Ion 
(Intensity %) 
Capillary(kV) Cone Voltage (V) 
m/z Product Ion 
(Intensity%) 
Collision 
Energy (eV) 
Retention Time 
Rt (min) 
Chloroamphenicol CAP 
(SSTD) 
ES− 325.0 (10) −4200 −35 
194.0 (100) 
152.0 (45) 
−18 
−20 
5.7 
Robenidine ES+ 334.1 (58) +5300 50 
138.0 (90) 
155.0 (100) 
35 
28 
6.7 
Toltrazuril 
Sulfoxide 
ES− 440.3 (60) −4200 −40 
42.1 (80) 
371.0(100) 
−25 
−22 
8.6 
Toltrazuril 
Sulfone 
ES− 
456.2 (10) 
456.2 (10) 
−4200 −40 
42.1 (100) 
456.0 (100) 
−30 
−10 
9.8 
Clazuril ES− 371.2 (9) −4200 −40 
299.9 (100) 
265.0 (39) 
−22 
−22 
9.8 
Nicarbazin/DNC ES− 301.0 (37) −4200 −40 
107.0(5) 
137.0 (100) 
−43 
−20 
10.1 
Diclazuril  ES− 
405.0 (6) 
406.9 (6) 
−4200 −40 
333.8 (100) 
335.8 (100) 
−25 
−25 
10.5 
Diclazuril-bis (ISTD) ES− 419.0 (20) −4200 −40 
321.0 (80) 
348.0(100) 
−22 
−20 
10.8 
Toltrazuril ES− 
424.0 (37) 
424.0 (37) 
−4200 −40 
42.1 (100) 
424.0 (100) 
−38 
−9 
10.9 
Toltrazuril-d3 (ISTD) ES− 427.0 (30) −4200 −40 42.1 (100) −38 10.9 
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3.2.Optimization of the Clean-Up Procedure 
The clean-up procedure was structured in the following steps:  
 optimization of the liquid–liquid extraction (nature and volume of solvent, time and pH of 
extraction) 
 optimization of the purification of the extracts (choice of the SPE cartridge, washing and elution 
conditions) 
Preliminary experiments were done directly on the standard solution of analytes for the choice 
of the conditions to meet the goals of the best extraction and purification steps. 
Successively, in order to optimize the clean-up procedure, 1g of egg, spiked with each analyte at 
different level, was used. In order to find the best extraction conditions, we tested different kinds of 
solvents in different volumes: AcN, ethyl acetate, and a mixture of ethyl acetate:acetone (50:50, v/v), 
different pH, extraction times, and extraction in ultrasonic bath and in the horizontal shaker. In 
Table 2, the extraction efficiency for the tested organic solvents is shown. The best recovery was 
obtained with AcN, on average, 85% for all the compounds. Good results were obtained with ethyl 
acetate too, except for robenedine, where the recovery was only 10%. The mixture of ethyl 
acetate/acetone 50:50 v/v improved the extraction of toltrazuril and its metabolites (80%), but 
decreased the recovery of the other compounds to 30%. The main concern using the ethyl 
acetate/acetone mixture is due to a higher extraction of the lipid components as well, which can 
cause interferences and higher background. 
Table 2.Extraction efficiency comparing different extraction solvents: ethyl acetate, acetonitrile, and 
ethyl acetate-acetone = 50:50. 
Compound 
Ethyl Acetate 
(xm ± σ)% 
Acetonitrile 
(xm ± σ)% 
Ethyl Acetate–Acetone =50:50 
(xm ± σ)% 
Robenidine 10±3.2 82 ± 1.0 33 ± 2.0 
Toltrazuril Sulfoxide 75 ± 2.2 72 ± 0.9 81+2.1 
Toltrazuril Sulfone 73 ± 1.5 70 ± 1.3 85 ± 1.5 
Clazuril 95 ± 3.1 95 ± 0.8 45 ± 1.0 
Nicarbazin/DNC 90 ± 2.8 98 ± 2.1 25 ± 4.2 
Diclazuril 88 ± 1.0 95 ± 1.1 31 ± 0.5 
Toltrazuril 75 ± 0.5 70 ± 1.5 82 ± 3.0 
xm average of three different tests. σ standard deviation. 
The optimum conditions in terms of time/volume of extraction were, respectively, 5 min in 
ultrasonic bath with 5mL of solvent. An additional 20 min in the horizontal shaker improved the 
extraction efficiency. The pH was another parameter under study. Acidifying at pH 5 or alkalizing at 
pH 9.5, the egg, before the extraction, did not improve the extraction efficiency (data not shown).In 
order to improve the sample clean-up, reducing the lipid components, a SPE procedure was 
mandatory. Different brands of polymeric SPE cartridges were tested: OASIS (Waters spa Milan, 
Italy), Strata X (Phenomenexsrl40013 – Castel Maggiore, Bo, Italy) and Varian. The extracts were 
diluted five times with Milli-Q water before being loaded in the cartridge. Two washing steps (5 mL 
each), the first one with water and the second one with aqueous methanol (5%, 10%, and 15%) were 
done before the elution step. The higher concentration of MeOH should facilitate the clean-up. It was 
observed that 5% aqueous MeOH was the best compromise to avoid the loss of analytes (data not 
shown). Both MeOH and AcN were tested for the elution step, but MeOH gave the best results. 
Strata X and Varian (60 mg) cartridges were comparable, but the Varian was more reproducible and 
gave slightly higher recovery for the target analytes, on average 80% with a coefficient of variation 
CV, calculated over three replicates, below 15%. The eluate was dried under nitrogen, reconstituted 
and analyzed in HPLC/ESI-MS/MS in MRM mode, as described above. We experimentally 
calculated the loss due to the evaporation step between 1% and 5%. 
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The acquisition has been divided into three periods: The first one between 0 and 6.2 min in 
negative ionization where the CAP is acquired, the second one between 6.2 and 7.5 min in positive 
mode where the robenidine is acquired and finally the third one between 7.5 and 12.0 min, where 
clazuril, diclazuril, toltrazuril sulfone, toltrazuril sulfoxide and nicarbazin are acquired. 
4. Validation Study 
The validation method was carried out according to the Revision of Commission 
Decision93/256/EC [32]; therefore, instrumental linearity, specificity, recovery, precision, CCα and 
CCβ and robustness were studied. 
4.1. Linearity and Matrix Effect 
The matrix effect can greatly affect the reproducibility and accuracy of the method. The 
linearity was checked for three days by calibration curve both in solution and in matrix (adding 
analytes and ISTDs at the end of the clean-up) in the following range of concentrations: 1–10 µg·kg−1 
for CLAZ and DCLAZ, (corresponding to 20–200 ng/mL in solution), and 5–20 µg·kg−1 for TOL and 
its metabolites (corresponding to 100–400 ng/mL in solution), 5–40 µg·kg−1 for ROB (corresponding 
to 100–800 ng/mL in solution) and 10–45 µg·kg−1for NIC (corresponding to 200–900 ng/mL in 
solution). The linearity in the investigated ranges was very good, as demonstrated by the correlation 
factors R2≥0.999 (data not shown). To evaluate matrix effects (ME) the slope of matrix matched 
calibration curves and the slope of standard calibration curveswere calculated. The slope ratio(R) 
×100 is defined as the matrix effect (ME %). A value of 100% indicates that there is no matrix effect. 
There is signal enhancement if the value is >100% and signal suppression if the value is <100% [35]. 
Thanks to the proposed clean-up procedure, reducing the interfering compounds in the matrix that 
alter the ionization in the source of the mass spectrometer, the solution and matrix-matched 
calibration curve equations had an ME % within 10%. Therefore, for quantitative purposes, we used 
the solvent calibration curves. 
4.2. Specificity 
Specificity was tested on 20 representative blank samples, compared to spiked ones with 
analytes and ISTD. The acquisition, as discussed previously, was divided intothree periods 
according to the retention time of the analytes. In the target regions, no interfering peaks were 
observed. 
4.3.Recovery 
Once the best extraction and clean-up conditions were chosen, the recovery of the whole 
procedure was determined for six spiked blank samples for each concentration level for three days. 
The levels were: 1,2, 3, 4, 6 µg·kg−1 for diclazuril and clazuril and 5, 7.5, 10 and 15 µg·kg−1 for TOL 
and its metabolites. For ROB, the levels were 5, 12.5, 25, 37.5 µg·kg−1, whereas, for NIC, the levels 
were 100, 150, 300,450 µg·kg−1 (applying the dilution factor of 10 to be inside the calibration curve 
range). The recovery was calculated by differences among nominal values of spiked blank samples 
and experimental values. The results were obtained by a solvent curve, since the matrix effect was 
not considerable, and the average recovery was about 80%, considering 62% as a minimum for the 
robenidine and 95% as a maximum for the toltrazuril, as shown in Table 3. 
Table 3.Results of recovery and precision of the method. 
Analyte 
Validation 
Level 
Experimental 
Concentration 
Recovery Repeatability Reproducibility 
(µg·kg−1) 
(µg·kg−1) ± σ 
(%) 
(CV%) (n = 6) 
(CV%) (n=18) 
(n=18) 1 2 3 
Robenedine 5.0 3.1± 0.4 62 13.7 14.7 11.9 13.9 
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12.5 8.5±0.8 68 11.5 10.1 9.0 11 
25.0 18.5±1.2 74 7.1 11 7.0 9 
37.5 28.5±2.5 76 8.0 10 13 12.0 
Toltrazuril 
Sulfoxide 
5.0 4.0 ± 0.5 80 13.0 7.5 7.5 13.6 
7.5 6.4 ± 0.6 85 5.7 4.6 10.5 10.2 
10.0 7.5 ± 0.6 75 9.4 8.8 8.4 9.2 
15.0 11.4 ± 1.3 76 8.2 13.2 12.5 11.5 
Toltrazuril 
Sulfone 
5.0 4.4 ± 0.5 88 9.6 4.2 11.5 11.6 
7.5 6.6 ± 0.6 88 9.1 5.4 11.4 9.2 
10.0 8.1 ± 0.9 81 12.2 7.8 8.4 10.5 
15.0 12.7 ± 1.1 85 5.0 10.1 11.4 8.6 
Clazuril 
1.0 0.8±0.1 80 12.5 11.9 12.1 12.0 
2.0 1.7 ± 0.2 85 12.4 7.9 11.0 11.0 
3.0 2.4 ± 0.2 80 6.1 8.4 8.5 8.9 
4.0 3.2 ± 0.3 80 3.2 10.3 10.3 10.2 
6.0 5.4 ± 0.3 90 2.9 4.8 8.0 8.7 
Nicarbazin 
100.0 75.0+9.0 75 11.0 9.0 13.0 12.0 
150.0 110.0+11.0 73 9.0 10.0 12.0 11.0 
300.0 234.0+10.0 78 5.0 8.0 7.0 8.0 
450.0 315.0+28 70 9.0 8.0 12.0 9.0 
100.0 75.0+9.0 75 11.0 9.0 13.0 12.0 
Diclazuril 
1.0 0.8±0.1 80 11.0 13.0 12.1 12.1 
2.00 1.8 ± 0.3 90 7.0 5.6 8.8 13.7 
3.0 2.6± 0.2 87 7.2 5.5 7.0 10.2 
4.0 3.2 ± 0.3 80 9.2 9.1 8.9 9.5 
6.0 5.1 ± 0.5 85 9.9 12.2 8.4 11.5 
Toltrazuril 
5.0 4.4 ± 0.3 88 9.3 7.7 8.8 14.1 
7.5 7.1 ± 0.5 95 5.5 4.1 9.5 6.4 
10.0 8.7 ± 0.9 87 11.7 12.4 10.1 10.9 
15.0 12.7 ± 1.2 85 8.1 9.2 11.3 9.8 
4.4. Precision: Repeatability and Reproducibility Intra-Laboratory 
Precision has been evaluated as repeatability and reproducibility intra-laboratory. Repeatability 
is measured as relative standard deviation (CV%) of repeated measures of six aliquots for each 
concentration level for three consecutive days, and the reproducibility as CV% of repeated measures 
of all three days (18 samples for each concentration level).The results are shown in Table 3; they are 
good for all analytes with CV% below 20% and they respect the recommendations of the 657/2002 
Directive. 
4.5. CCα and CCβ and Robustness (Minor Changes) 
The decision limit (CCα) and the detection capability (CCβ) has been estimated according to 
Lynn Vanhaecke et al. [36] and Commission Decision 2002/657/EC [34].  
The CCα is between 2.2μg·kg−1 for diclazuril and 320 μg·kg−1 for nicarbazine, whereas the CCβ 
is between 2.2 μg·kg−1 for diclazuril and 350 μg·kg−1 for nicarbazine. The results are reported in Table 
4. Robustness has been evaluated by Youden test on eight spiked blank samples at the CCβ 
concentration level. The parameters shown in Table 5 were chosen to evaluate how small changes 
can affect the proposed method, so one variable was chosen in the extractive step (extraction 
volume) and the other five variables in the purification step, including the stability of analytes at the 
boiling point of the solvent. The effect of each factor was calculated by determining the difference 
between the value of the variable at the highest and at the lowest level. Differences were not 
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significant; in other words, the investigated parameters have no effect on the characteristics of the 
method, and, therefore, the method can be defined robust. 
Table 4.CCα and CCβ values for the investigated analytes. 
Analyte CCα (µg·kg−1) CCβ (µg·kg−1) 
Robenidine 28.0 30.0 
Toltrazuril sulfoxide 5.1 6.1 
Toltrazuril sulfone 5.8 6.7 
Clazuril 2.2 2.6 
Nicarbazin/DNC 320.0 350.0 
Diclazuril 2..2 2.6 
Toltrazuril 6.0 6.9 
CCα Decision limit 
Table 5.Youden experiment table for the robustness of the method. 
Variable Number 
Experiment Number 
1 2 3 4 5 6 7 8 
Lot of SPE lotA lotA lotA lotA lotA lotA lotA lotA 
Extraction Volume Acetonitrile (mL) 5.5 5.5 4.5 4.5 5.5 5.5 4.5 4.5 
Dilution Volume with Water (mL) 30 20 30 20 30 20 30 20 
Washing Volume for SPE with Water (mL) 5.5 5.5 4.5 4.5 4.5 4.5 5.5 5.5 
Washing Volume for SPE with MeOH 5% (mL) 5.5 4.5 5.5 4.5 4.5 5.5 4.5 5.5 
Elution Volume for SPE (mL) 5.5 4.5 4.5 5.5 5.5 4.5 4.5 5.5 
Drying temperature (°C) 44 36 36 44 36 44 44 36 
SPE solid phase extraction cartridge 
5. Conclusions 
Due to the massive use of coccidiostats in poultry farming, for the prevention and treatment of 
coccidiosis, we developed a sensitive, simple, rapid and robust LC-MS/MS method, to detect, in 
eggs, simultaneously different synthetic coccidiostats for a total of seven analytes (five compounds 
and two metabolites), usually not analysed all together. Possible critical factors were examined and 
several clean-up strategies were tested to find the parameters and the conditions to meet the goals of 
the best extraction and purification step for screening and confirmation purposes. Experimental data 
showed that, thanks to a proper sample preparation, the matrix effect was drastically decreased, 
reducing the endogenous substances liable to interfere with the assay. This circumstance allowed us 
to use the solvent calibration curve for quantitative purposes. 
The method has been validated in conformity with the main lines of the UE requirements for 
detecting residues of veterinary drugs in animal products and can be used to detect residues, in 
eggs, of the five coccidiostats at the level of µg/kg. 
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